As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

A common medication may help prevent dementia and Alzheimer's disease—but researchers are still trying to figure out why, and ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

The symptoms of alcohol-related dementia can vary, but they usually involve changes in how a person thinks and acts. Some ...

Previous research has associated sleep medications with other health risks, such as falls, fractures, car accidents, and ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...

2024 — A drug commonly used to treat glaucoma has been shown in zebrafish and mice to protect against the build-up in the brain of the protein tau, which causes various forms of dementia and is ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...